Novartis Gene Therapies, Inc. et al. v. Genzyme Corporation et al. > Summary
Court Case Number IPR2023-00609
Filing Date Feb 22, 2023
Institution Decision Date Aug 30, 2023
Decision Date Aug 30, 2023
Court Patent Trial and Appeal Board
Status Institution Denied
Administrative JudgesJames A. Tartal, Jeffrey N. Fredman, Sheridan K. Snedden
Judge Writing the Final DecisionJames A. Tartal
Claims Challenged in the Petition: 1, 2, 5, 6
Petitioner
Patent Owner
Petitioner Attorneys
7Novartis Gene Therapies, Inc.
Attorney Name: Cora R. Holt
Finnegan, Henderson, Farabow, Garrett & Dunner
Novartis Gene Therapies, Inc.
Attorney Name: Yieyie Yang
Finnegan, Henderson, Farabow, Garrett & Dunner
Novartis Gene Therapies, Inc.
Attorney Name: Amanda K. Murphy
Finnegan, Henderson, Farabow, Garrett & Dunner
Novartis Gene Therapies, Inc.
Attorney Name: Christopher W. Weber
Finnegan, Henderson, Farabow, Garrett & Dunner
Novartis Gene Therapies, Inc.
Attorney Name: John D. Livingstone
Finnegan, Henderson, Farabow, Garrett & Dunner
Novartis Gene Therapies, Inc.
Attorney Name: David Weingarten
Finnegan, Henderson, Farabow, Garrett & Dunner
Novartis Gene Therapies, Inc.
Attorney Name: Lauren K. Young
Finnegan, Henderson, Farabow, Garrett & Dunner
Patent Owner Attorneys
7Sanofi
Attorney Name: Amanda K. Antons
Dechert
Sanofi
Attorney Name: Katherine A. Helm
Dechert
Sanofi
Attorney Name: Blaine M. Hackman
Dechert
Sanofi
Attorney Name: James L. Lovsin
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Dmitriy A. Vinarov
McDonnell Boehnen Hulbert & Berghoff LLP
Sanofi
Attorney Name: Paul H. Berghoff
McDonnell Boehnen Hulbert & Berghoff LLP
Dechert
Attorney Name: Martyn C. Davies
Dechert
Related Patents
Doc No | Title | Issue date |
---|---|---|
09051542 | Compositions and methods to prevent AAV vector aggregation | Jun 9, 2015 |